Arrowhead Pharmaceuticals, Inc. (ARWR)
62.64
-1.88
(-2.91%)
USD |
NASDAQ |
Feb 09, 16:00
62.70
+0.06
(+0.10%)
After-Hours: 20:00
Arrowhead Pharmaceuticals EPS Diluted (Quarterly) : 0.219 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -1.795 |
| Eli Lilly & Co. | 7.390 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Sanofi | -- |
| Cidara Therapeutics, Inc. | -3.096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.24M |
| Revenue (Quarterly) | 264.03M |
| Total Expenses (Quarterly) | 233.22M |
| Enterprise Value | 8.537B |
| Gross Profit Margin (Quarterly) | 97.58% |
| Profit Margin (Quarterly) | 10.70% |
| Earnings Yield | 2.46% |
| Operating Earnings Yield | 3.49% |
| Normalized Earnings Yield | 2.456 |